Results 11 to 20 of about 588,357 (198)

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics [PDF]

open access: yesВопросы современной педиатрии, 2020
The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov   +2 more
doaj   +2 more sources

Localized scleroderma – current treatment options

open access: yesPrzegląd Dermatologiczny, 2017
Localized scleroderma (morphea) is a connective tissue disease that affects the skin, subcutaneous tissue and underlying tissues including the fasciae, muscles and bones. The treatment of localized scleroderma depends on the clinical form of the disease,
Katarzyna Wolska-Gawron   +2 more
doaj   +2 more sources

Localized scleroderma: A rare clinical entity

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2014
Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ranjana Garg   +2 more
doaj   +2 more sources

LOCALIZED SCLERODERMAS

open access: yesCurrent Opinion in Rheumatology, 2006
Localized scleroderma, also known as morphoea, has a variety of clinical manifestations that can include systemic involvement. Early recognition, diagnosis and treatment may improve the long-term outcome.A large multicentre study coordinated by the Pediatric Rheumatology European Society has yielded important information on the epidemiology and ...
Ronald M, Laxer, Francesco, Zulian
openaire   +3 more sources

Localized scleroderma – classification and tools used for the evaluation of tissue damage and disease activity/severity [PDF]

open access: yesPrzegląd Dermatologiczny, 2017
Localized scleroderma is a rare autoimmune disorder affecting the dermis, subcutaneous tissue and deeper structures. The course of localized scleroderma includes three stages: early inflammation, progressive sclerosis and atrophy. The active stage of the
Katarzyna Wolska-Gawron   +1 more
doaj   +2 more sources

Congenital localized scleroderma

open access: yesThe Journal of Pediatrics, 2006
Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS).A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history,
Zulian F   +8 more
openaire   +3 more sources

Fat graft and platelet-rich plasma treatment for localized facial scleroderma

open access: yesTurkish Journal of Plastic Surgery, 2021
Scleroderma is an autoimmune disorder characterized by hardening of the skin on the hands, arms, and face. Immunosuppressors, vasodilators, and physiotherapy are among the treatments for scleroderma. Although these treatments can improve quality of life,
Ali Gokkaya   +5 more
doaj   +2 more sources

Modern methods of a localized scleroderma diagnostics [PDF]

open access: yesСаратовский научно-медицинский журнал, 2016
Localized scleroderma (LS) is a disease that is characterized by the appearance of inflammatory, sclerotic and/or atrophic changes in the affected areas of the skin and underlying tissues.
Moiseyev А.А., Utz S.R.
doaj   +1 more source

Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy

open access: yesJournal of Cutaneous Immunology and Allergy, 2022
A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma ...
Sayuko Nagaoka   +2 more
doaj   +2 more sources

Localized scleroderma in a newborn (case report) [PDF]

open access: yesРМЖ. Мать и дитя, 2022
N.I. Akhmina1, P.S. Utkin2, M.P. Shalatonin3, Zh.L. Chabaidze1, A.A. Dement’ev1, A.L. Zaplatnikov1 1Russian Medical Academy of Continuous Professional Education, Moscow,   Russian Federation 2Children’s Infectious Clinical Hospital
N.I. Akhmina   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy